The document outlines a Request for Proposals (RFP) issued by the U.S. Department of Agriculture's Agricultural Research Service for the delivery of essential animal vaccines necessary for research at the Roman L. Hruska U.S. Meat Animal Research Center. The specified vaccines, mainly for beef cattle, swine, and sheep, must be delivered by January 3, 2025, with strict adherence to expiration date criteria of January 1, 2026, or later. The document lists various vaccines, including Brute Pour On, Cydectin Pour-On, and several Pyramid formulations, providing details on required sizes and quantities. The contractor will be expected to facilitate a one-time delivery during standard business hours, with access to the facility provided by the government. Any vaccines failing to meet the expiration criteria will be rejected. This RFP emphasizes the USDA's commitment to maintaining animal health in its research endeavors within the agricultural sector.
The United States Department of Agriculture (USDA) is soliciting quotes for the provision of various animal vaccines through RFQ 12805B25Q0026. This procurement is fully set aside for small businesses, and interested vendors must register with the System for Award Management (SAM). The applicable NAICS code is 325414, which pertains to Biological Product Manufacturing, with a size standard of 1,250 employees. The solicitation includes several contract line items (CLIN), outlining specific vaccines required, their sizes, quantities, and expiration dates, all set for delivery by January 3, 2025. Vendors must submit their quotes electronically to a specified USDA email address, along with a summary cover letter and necessary certifications. The evaluation will be based on the Lowest Price Technically Acceptable (LPTA) method, considering compliance with the requirements, authorized vendor status, and past performance evaluations. Additional clauses and provisions relevant to federal contracting standards are incorporated, ensuring adherence to regulations focused on fair labor practices, anti-trafficking policies, and procurement integrity. The document highlights the USDA's initiative to acquire essential biopharmaceutical products from qualified small businesses while promoting regulatory compliance and ethical procurement practices.